Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Novartis knocks Pfizer off sales leader board

Novartis knocks Pfizer off sales leader board and a strong pipeline of drugs across multiple therapy areas, has helped it stave off major losses from the $6bn a year sales once coming from its blood pressure pill Diovan

Novartis' heart failure drug could get FDA nod in summer

Novartis' heart failure drug could get FDA nod in summer It has also been granted a priority review in Switzerland. LCZ696 is a follow-up to Novartis' big-selling angiotensin II receptor antagonist Diovan (valsartan) - combining the AIIRA with novel neprilysin

Novartis' Japanese subsidiary threatened with suspension

Novartis' Japanese subsidiary threatened with suspension Last year, prosecutors in Japan laid formal charges against Novartis in an ongoing investigation about the manipulation of clinical data, centring on studies of the company's blood pressure treatment Diovan

FDA panel votes against Actavis hypertension combo

FDA panel votes against Actavis hypertension combo Places a question mark over the combination of Bystolic and Diovan. ... Valsartan - an angiotensin II receptor blocker - was until recently marketed solely by Novartis as Diovan, becoming one of the world's biggest selling drugs with sales topping $4bn.

Milestone names chief medical officer

Milestone names chief medical officer His other big pharma experience includes roles at Daiichi-Sankyo, Novartis, and Bristol Myers Squibb, working on cardiovascular products including Efient, Diovan and Approvel.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics